Comerica Bank
NGNE icon

Comerica Bank’s Neurogene NGNE Stock Holding History

Comerica Bank’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-40
Closed -$1.68K – 3721
2024
Q3 		$1.68K Buy
+40
New +$1.55K ﹤0.01% 3525

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Comerica Bank's NGNE Position: Q4 2024 in Review

Comerica Bank sold out of Neurogene (NGNE) in Q4 2024, closing a stake of 40 shares — an estimated $1.68K sold.

Comerica Bank first reported a position in NGNE in Q3 2024 and held it in 1 quarter. The position peaked at $1.68K in Q3 2024. 88 funds tracked by Wall St. Rank hold NGNE as of Q4 2024.

  • Comerica Bank reported no remaining Neurogene position as of Q4 2024 after selling out during the quarter.
  • Comerica Bank sold 40 Neurogene shares in Q4 2024, an estimated $1.68K.
  • Comerica Bank first reported a position in Neurogene in Q3 2024 and held it in 1 quarter.
  • Comerica Bank's Neurogene position peaked at $1.68K in Q3 2024.
  • 88 funds tracked by Wall St. Rank held Neurogene as of Q4 2024.

Based on Comerica Bank's 13F filing for Q4 2024, filed 14 Feb 2025.